尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Cathie MARSAIS, Directrice Générale Déléguée, Opérations et Affaires réglementaires. Insider active across 1 company, notably EUROBIO-SCIENTIFIC. Cumulatively, 1 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €75k. History available since 5 December 2024. The latest transaction was filed on 5 December 2024 (Apport à une offre publique d'acquisition). Regulator: AMF. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Cathie Marsais holds a key leadership role at Eurobio Scientific, a French listed group specialized in in vitro diagnostics and life sciences. She joined the company in 2007 as Quality Manager and has since progressed to the position of Deputy General Director, with responsibility for operations and regulatory affairs. As a member of the group’s Executive Committee, she now oversees strategic functions that underpin the company’s industrial and operational performance, including supply chain, production, R&D, quality, and regulatory services. She also serves as a key representative of management with French and European health-product regulatory authorities. With more than 18 years of experience in in vitro diagnostics and medical devices, Cathie Marsais has built a profile at the intersection of science, industrial execution, and regulatory compliance. Her career reflects deep expertise in highly regulated environments, where quality assurance, process control, and operational discipline are critical. She holds a master’s degree in biotechnology and health products from the Pharmaceutical University of Châtenay-Malabry, as well as an Executive MBA from EM Lyon, a combination that highlights both technical and managerial strengths. At Eurobio Scientific, she contributes to the group’s transformation and growth by aligning regulatory requirements, product quality, industrial organization, and development objectives. Her role is particularly significant in a sector where operational resilience and supply-chain reliability are essential to serving laboratories and healthcare providers effectively.